Focused on High Value Cells

Solentim to launch the ICON™ in 2021

Solentim is happy to announce that its new Cell Line Development platform, the ICON, will launch early 2021. For over a decade, Solentim has provided leading solutions to create, isolate and characterize the highest value cells, accelerating the development of new biological medicines and therapies around the world, in cell line development, vaccine research, stem …

Read more Solentim to launch the ICON™ in 2021